JAM3 and neoplasm: Targeting JAM-C may have therapeutic usage in suppressing inflammation (Palmer et al., 2007; Shagdarsuren et al., 2009; Hirano et al., 2018), angiogenesis, and tumor growth (Lamagna et al., 2005) by inhibiting the infiltration of macrophages.